vasomotor function and lipid metabolism of the arterial wall. It is our hope that a genetic profile of critical mutations may provide a portraiture of stroke-prone subjects for whom precise interventions to prevent strokes can be designed. Studies we are pursuing involve the gene defect in the angiotensin-converting enzyme, specifically the double alu-sequence deletion in the 16th intron2; lipoprotein (a) analyses3'4; apoprotein E5; and factors influencing the proliferation of cerebral arterial smooth muscle and endothelial cells.
Diaschisis is a well-known phenomenon in stroke patients, although the mechanism is still controversial.2 We did not mention that the reduction of cerebral blood flow is due to or specific to poststroke depression. Rather, our argument is that depression may be based on the reduction of cerebral blood flow (CBF) whatever the reason for CBF reduction. Diaschisis may be one of the major reasons for the reduction.
We agree with his point that a time factor contributed to changes in both CBF and depression score. However, our point is whether two variables were independently or interactively affected by the time factor. Our longitudinal data suggest that the latter is the case.
It is a statistical rule that data from correlational research can be interpreted only in causal terms based on some theories that we have, and correlational data cannot conclusively prove causality. We noted a caution in drawing conclusions from our correlational data, but in conjunction with the data from other lesion studies,3 our data suggest that decrease of regional CBF in certain brain area contributes to depression.
His proposals should be appreciated for future studies, but at least some of his suggestions have been already considered in our report. First, we did not exclude nondepressed patients from the study. We had criteria for selecting subjects, but those were for avoiding effects of medication or dementia and not for excluding nondepressed patients. Second, we used a type of prospective follow-up in our study. Some patients developed depression and some showed alleviation of depression during the follow-up period in association with the changes in regional CBF, which were shown in Figures 2 and 3 
